Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

0 of 8 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

3(33.3%)

Phase 3

2(22.2%)

Phase 4

2(22.2%)

Phase 1

1(11.1%)

N/A

1(11.1%)

9Total

Phase 2(3)

Phase 3(2)

Phase 4(2)

Phase 1(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04355637Phase 4Completed

Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia

Role: lead

NCT02283671Phase 1Completed

Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 B

Role: lead

NCT01986127Phase 3Terminated

Adalimumab Intralesional in Intestinal Strictures of Crohn's Disease Patients

Role: lead

NCT02117908Not ApplicableCompleted

Study of the Application of CPAP to Reduce Complications and Improve Lung Cancer Ablation Radiofrequency Treatment

Role: lead

NCT01601314Phase 3Completed

Perioperative Magnesium Sulphate as a Cerebral Protector in Neurosurgical Patients

Role: lead

NCT02279511Phase 2Completed

ATP in Alzheimer Disease

Role: lead

NCT01575574Phase 4Completed

Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis

Role: lead

NCT01616615Phase 2Completed

Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of Gestation

Role: lead

NCT01577121Phase 2Completed

Evaluation of the Use of Indomethacin as Co-treatment in Women With Preterm Labor and High Risk of Intraamniotic Inflammation

Role: lead

All 9 trials loaded